One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies

Background Despite currently available standard-of-care inhaled corticosteroid (ICS)/long-acting β2-agonist therapies, a substantial proportion of patients with asthma remain inadequately controlled. This pooled analysis evaluated efficacy and safety of mometasone furoate/indacaterol acetate (MF/IND...

Full description

Saved in:
Bibliographic Details
Main Authors: Huib A M Kerstjens, Motoi Hosoe, Yasuhiro Gon, Kenneth Chapman, Ana-Maria Tanase, Richard van Zyl-Smit, Jorge Maspero, Abhijit Pethe, Xu Shu, Peter D’Andrea
Format: Article
Language:English
Published: BMJ Publishing Group 2021-01-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/8/1/e000819.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopenrespres.bmj.com/content/8/1/e000819.full

Similar Items